South Florida Optometics is categorized under Kidney Dialysis Centers in Hollywood, FL .
South Florida Optometics was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6213200 by the NAICS.
If you are seeking more information, feel free to contact Michael Holfield, Owner at the company’s single location by writing to 4000 Oakwood Boulevard, Hollywood, Florida FL 33020 or by phoning (954) 684-9200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | South Florida Optometics |
Contact Person: | Michael Holfield, Owner |
Address: | 4000 Oakwood Boulevard, Hollywood, Florida 33020 |
Phone Number: | (954) 684-9200 |
Website Address: | mosestaylorhospital.net |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Kidney Dialysis Centers |
SIC Code: | 8092 |
NAICS Code: | 6213200 |
Share This Business: |
South Florida Optometics was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6213200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Holfield, Owner for inquiries that concern South Florida Optometics by calling the company number (954) 684-9200, as your correspondence is most welcome. Additionally, the physical location of the single location of South Florida Optometics can be found at the coordinates 26.0463,-80.16005 as well as the street address 4000 Oakwood Boulevard in Hollywood, Florida 33020.
For its online presence, you may visit South Florida Optometics’s website at mosestaylorhospital.net and engage with its social media outlets through on Twitter and on Facebook.